Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress

Journal of Periodontology

Volumn 78, Issue 3, 2007, Pages 576-583

  Cutando, Antonio ^a   Arana, Carlos ^a   Gómez Moreno, Gerardo ^a   Escames, Germaine ^a   López, Ana ^a   Ferrera, María J ^a   Reiter, Russel J ^b   Acuña Castroviejo, Darío ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Antioxidant; Free radicals; Mouth; Oral surgery; Oxidative stress

Indexed keywords

ANTIOXIDANT; MELATONIN; NITRATE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; DOG; DRUG EFFECT; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; TOOTH EXTRACTION; TOOTH SOCKET; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; DOGS; LIPID PEROXIDATION; MALE; MELATONIN; NITRATES; OXIDATIVE STRESS; TOOTH EXTRACTION; TOOTH SOCKET;

EID: 33947679750     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060244     Document Type: Article

References (50)

1. Minczykowski A, Woszczyk M, Szczepanik A, Lewandowski L, Wysocki H. Hydrogen peroxide and superoxide anion production by polymorphonuclear neutrophils in patients with chronic periapical granuloma, before and after surgical treatment. Clin Oral Investig 2001;5:6-10.
2. Waddington RJ, Moseley R, Embery G. Reactive oxygen species: A potential role in the pathogenesis of periodontal diseases. Oral Dis 2000;6:138-151.
3. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 2000;24:239-252.
4. Daghigh F, Borghaei RC, Thornton RD, Bee JH. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 2002;73:392-400.
5. Kimura S, Yonemura T, Kaya H. Increased oxidative product formation by peripheral blood PMN leukocytes in human periodontal diseases. J Periodontal Res 1993;28:197-203.
6. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond) 2003;105:167-172.
7. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004;34:379-385.
8. Chaiyarit P, Ning MA, Hiraku Y, et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 2005;96: 553-559.
9. Cerutti PA. Oxy-radicals and cancer. Lancet 1994;344: 862-863.
10. Altman LC, Baker C, Fleckman P, Luchtel D, Oda D. Neutrophil-mediated damage to human gingival epithelial cells. J Periodontal Res 1992;27:70-79.
11. Lohinai Z, Stachlewitz R, Virag L, Szekely AD, Hasko G, Szabo C. Evidence for reactive nitrogen species formation in the gingivomucosal tissue. J Dent Res 2001;80:470-475.
12. Page RC, Kornman KS. The pathogenesis of human periodontitis: An introduction. Periodontol 2000 1997; 14:9-11.
13. McMillan MD. Neutrophils in the molar tooth extraction wound in the rat: A transmission electron microscope (TEM) study. J Oral Pathol Med 1999;28:297-302.
14. Shapira L, Borinski R, Sela MN, Soskolne A. Super-oxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 1991;18: 44-48.
15. Deguchi S, Hori T, Creamer H, Gabler W. Neutrophil-mediated damage to human periodontal ligament-derived fibroblast: Role of lipopolysaccharide. J Periodontal Res 1990;25:293-299.
16. Diab-Ladki R, Pellat B, Chahine R. Decrease in the total antioxidant activity of saliva in patients with periodontal diseases. Clin Oral Investig 2003;7:103-107.
17. Ohashi M, Iwase M, Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med 1999;28:355-359.
18. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X, Kawanishi S. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 2006;14: 137-143.
19. Acuña-Castroviejo D, Martín M, Macías M, et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30:65-74.
20. Tan DX, Reiter RJ, Manchester CL, et al. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002;2: 181-197.
21. Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M, Calvo JR. Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept 2000;9:137-159.
22. León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005;38:1-9.
23. Pablos MI, Agapito MT, Gutierrez I, et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995;19:111-115.
24. Antolín I, Rodríguez C, Sainz RM, et al. Neurohormone melatonin prevents cell damage: Effect on gene expression of antioxidative enzymes. FASEB J 1996; 10:882-890.
25. Rodríguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 2004;36:1-9.
26. Martín M, Macías M, Escames G, León J, Acuña-Castroviejo D. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 2000;14:1677-1679.
27. Urata Y, Honma S, Goto S, et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999;27:838-847.
28. Crespo E, Macías M, Pozo D, et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999;13:1537-1546.
29. Escames G, León J, Macías M, Khaldy H, Acuña-Castroviejo D. Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J 2003;17: 932-934.
30. Gómez-Moreno G, Cutando-Soriano A, Arana C, et al. Melatonin expression in periodontal disease. J periodont Res 2007; in press.
31. Cutando A, Silvestre FJ. Melatonin: Implications at the oral level. Bull Group Int Rech Sci Stomatol Odontol 1995;38:81-6.
32. Brennan PA, Thomas GJ, Langdon JD. The role of nitric oxide in oral diseases. Arch Oral Biol 2003;48: 93-100.
33. Esterbauer H, Cheeseman KH. Determination of aldehidic lipid peroxidation products: Malonaldehide and 4-hydroxynonenal. Methods Enzymol 1990;186: 407-421.
34. Verdon CP, Burton BA, Prior RL. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224: 502-508.
35. Hissin PJ, Russel H. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
36. Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965;8: 141-187.
37. Jaskot RH, Charlet EG, Grose EC, Grady MA, Roycroft JH. An automatic analysis of glutathione peroxidase, glutathione-S-transferase, and reductase activity in animal tissue. J Anal Toxicol 1983;7:86-88.
38. Altman LC, Baker C, Fleckman P, Luchtel D, Oda D. Neutrophil-mediated damage to human gingival epithelial cells. J Periodontal Res 1992;27:70-79.
39. Xie Q, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/ Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269:4705-4708.
40. Cutando A, Galindo P, Gómez-Moreno G, et al. Relationship between salivary melatonin and severity of periodontal disease. J Periodontol 2006;77:1533-1538.
41. Escames G, López LC, Tapias V, et al. Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res 2006; 40:71-78.
42. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001;34: 237-256.
43. García JJ, Reiter RJ, Guerrero JM, et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408:297-300.
44. Bongiorno D, Ceraulo L, Ferrugia M, Fillizzola F, Ruggierello A, Liveri VT. Localization and interactions of melatonin in dry cholesterol/ lecithin mixed reversed micelles used as cell membrane models. J Pineal Res 2005;38:292-298.
45. Blanchard B, Pompon D, Ducrocq C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000;29:184-192.
46. Reiter RJ. Melatonin: Lowering the high price of free radicals. News Physiol Sci 2000;15:246-250.
47. Kir HM, Dillioglugil MO, Tugay M, Eraldemir C, Ozdogan HK. Effects of vitamins E, A and D on MDA, GSH, NO levels and SOD activities in 5/6 nephrectomized rats. Am J Nephrol 2005;25:441-446.
48. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 1996;12:274-277.
49. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. Epub 2006 Aug 4.
50. Battino M, Bullón P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: The challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 1999;10: 458-476.